JAK2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.113600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.902020E-01
Normal-vs-Stage2
4.428200E-02
Normal-vs-Stage3
2.258800E-01
Normal-vs-Stage4
3.805400E-01
Stage1-vs-Stage2
9.607800E-01
Stage1-vs-Stage3
2.035000E-01
Stage1-vs-Stage4
5.349000E-01
Stage2-vs-Stage3
2.876100E-03
Stage2-vs-Stage4
5.611200E-01
Stage3-vs-Stage4
3.058400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.542000E-02
Normal-vs-AfricanAmerican
4.659000E-01
Normal-vs-Asian
9.792500E-02
Caucasian-vs-AfricanAmerican
3.781600E-01
Caucasian-vs-Asian
7.191000E-01
AfricanAmerican-vs-Asian
4.305600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.600300E-02
Normal-vs-Female
6.455800E-02
Male-vs-Female
4.727800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.438000E-01
Normal-vs-Age(41-60Yrs)
5.899900E-02
Normal-vs-Age(61-80Yrs)
5.133900E-02
Normal-vs-Age(81-100Yrs)
8.460100E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.066400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.112200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.923800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.270600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.508600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.485800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.879800E-01
Normal-vs-Daily Drinker
2.651800E-01
Normal-vs-Weekly Drinker
2.201800E-01
Normal-vs-Occasional Drinker
3.198400E-01
Normal-vs-Social Drinker
2.983400E-01
Non Drinker-vs-Daily Drinker
5.608200E-01
Non Drinker-vs-Weekly Drinker
1.421620E-01
Non Drinker-vs-Occasional Drinker
5.798800E-01
Non Drinker-vs-Social Drinker
1.281420E-01
Daily Drinker-vs-Weekly Drinker
8.153700E-02
Daily Drinker-vs-Occasional Drinker
3.087400E-01
Daily Drinker-vs-Social Drinker
7.687900E-02
Weekly Drinker-vs-Occasional Drinker
2.624000E-01
Weekly Drinker-vs-Social Drinker
8.739800E-01
Occasional Drinker-vs-Social Drinker
2.467600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.873800E-01
Normal-vs-Grade 2
2.697800E-01
Normal-vs-Grade 3
3.669000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.788200E-01
Grade 1-vs-Grade 3
6.613200E-01
Grade 1-vs-Grade 4
4.873800E-01
Grade 2-vs-Grade 3
9.916600E-01
Grade 2-vs-Grade 4
2.697800E-01
Grade 3-vs-Grade 4
3.669000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.963600E-02
Normal-vs-NonDiabetic
3.319400E-01
Diabetic-vs-NonDiabetic
8.020000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.625400E-01
Normal-vs-NoPancreatitis
2.453500E-02
Pancreatitis-vs-NoPancreatitis
7.570300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.096400E-01
Normal-vs-N1
3.614200E-01
N0-vs-N1
7.080800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.373000E-01
Normal-vs-TP53-NonMutant
2.552400E-01
TP53-Mutant-vs-TP53-NonMutant
3.122300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
